NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
-24.47%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$4.95B
AUM Growth
+$4.95B
(-41%)
Cap. Flow
+$313M
Cap. Flow
% of AUM
6.33%
Top 10 Holdings %
Top 10 Hldgs %
77.21%
Holding
70
New
7
Increased
1
Reduced
6
Closed
12
Top Buys
| 1 |
IonQ
IONQ
|
$488M |
| 2 |
Cloudflare
NET
|
$130M |
| 3 |
BuzzFeed
BZFD
|
$81.7M |
| 4 |
NextNav
NN
|
$71.7M |
| 5 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$51.4M |
Top Sells
| 1 |
BILL Holdings
BILL
|
$123M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$101M |
| 3 |
Robinhood
HOOD
|
$59.5M |
| 4 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$51.8M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$48.1M |
Sector Composition
| 1 | Healthcare | 41.06% |
| 2 | Financials | 26.07% |
| 3 | Technology | 16.75% |
| 4 | Consumer Staples | 7.84% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Robinhood
HOOD
$92.4B
| $1.27B | 25.65% | 71,468,726 -3,349,672 | -4% | -$59.5M |
|
2
NeueHealth
NEUE
$59.2M
| $751M | 15.17% | 218,212,128 | – | – |
|
|
3
IonQ
IONQ
$12.7B
| $488M | 9.86% | +29,229,659 | New | +$488M |
|
4
Coursera
COUR
$1.88B
| $388M | 7.84% | 15,867,769 | – | – |
|
|
5
Cloudflare
NET
$72.7B
| $247M | 4.99% | 1,877,510 +987,751 | +111% | +$130M |
|
|
BGRY
6
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $210M | 4.25% | 38,226,621 | – | – |
|
7
Monte Rosa Therapeutics
GLUE
$296M
| $157M | 3.18% | 7,703,205 | – | – |
|
8
CRISPR Therapeutics
CRSP
$4.71B
| $120M | 2.44% | 1,590,002 | – | – |
|
|
OYST
9
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $108M | 2.19% | 5,925,287 | – | – |
|
|
10
BuzzFeed
BZFD
$72.6M
| $81.7M | 1.65% | +15,333,892 | New | +$81.7M |
|
|
11
NextNav
NN
$2.37B
| $71.7M | 1.45% | +8,189,156 | New | +$71.7M |
|
|
DM
12
DELISTED
Desktop Metal, Inc.
DM
| $71.3M | 1.44% | 14,407,594 | – | – |
|
|
13
Aurinia Pharmaceuticals
AUPH
$1.58B
| $70.2M | 1.42% | 3,069,834 -2,102,849 | -41% | -$48.1M |
|
14
Mirum Pharmaceuticals
MIRM
$3.71B
| $66.8M | 1.35% | 4,187,801 | – | – |
|
|
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
| $64.1M | 1.29% | 17,082,611 | – | – |
|
|
UTRS
16
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $51.4M | 1.04% | +9,999,125 | New | +$51.4M |
|
17
Rhythm Pharmaceuticals
RYTM
$6.85B
| $49M | 0.99% | 4,912,306 | – | – |
|
18
Nkarta
NKTX
$151M
| $44.6M | 0.9% | 2,904,974 | – | – |
|
|
CSPR
19
DELISTED
Casper Sleep Inc.
CSPR
| $41.6M | 0.84% | 6,226,130 | – | – |
|
|
OKUR
20
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $40.9M | 0.83% | 4,786,921 | – | – |
|
|
AKUS
21
DELISTED
Akouos, Inc. Common Stock
AKUS
| $36.5M | 0.74% | 4,298,488 | – | – |
|
|
VRNA
22
Verona Pharma
VRNA
$9.16B
| $34.3M | 0.69% | 5,108,563 | – | – |
|
23
VistaGen Therapeutics
VTGN
$102M
| $31.8M | 0.64% | 16,302,596 | – | – |
|
24
Savara
SVRA
$567M
| $29.9M | 0.6% | 24,137,931 | – | – |
|
25
CVRx
CVRX
$205M
| $29M | 0.59% | 2,370,858 | – | – |
|